Cargando…
STK899704 inhibits stemness of cancer stem cells and migration via the FAK-MEK-ERK pathway in HT29 cells
Colon cancer is one of the most lethal and common malignancies worldwide. STK899704, a novel synthetic agent, has been reported to exhibit anticancer effects towards numerous cancer cells. However, the effect of STK899704 on the biological properties of colon cancer, including cancer cell migration...
Autores principales: | Jang, Hui-Ju, Bak, Yesol, Pham, Thu-Huyen, Kwon, Sae-Bom, Kim, Bo-Yeon, Hong, JinTae, Yoon, Do-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Biochemistry and Molecular Biology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283024/ https://www.ncbi.nlm.nih.gov/pubmed/30269740 http://dx.doi.org/10.5483/BMBRep.2018.51.11.180 |
Ejemplares similares
-
Anticancer activity of a novel small molecule tubulin inhibitor STK899704
por: Sakchaisri, Krisada, et al.
Publicado: (2017) -
The Novel Small Molecule STK899704 Promotes Senescence of the Human A549 NSCLC Cells by Inducing DNA Damage Responses and Cell Cycle Arrest
por: Park, Chan-Woo, et al.
Publicado: (2018) -
IL-32θ inhibits stemness and epithelial-mesenchymal transition of cancer stem cells via the STAT3 pathway in colon cancer
por: Bak, Yesol, et al.
Publicado: (2016) -
Role of MEK partner-1 in cancer stemness through MEK/ERK pathway in cancerous neural stem cells, expressing EGFRviii
por: Kwon, Soo-Jung, et al.
Publicado: (2017) -
EDIL3 influenced the αvβ3‐FAK/MEK/ERK axis of endothelial cells in psoriasis
por: Niu, Xuping, et al.
Publicado: (2022)